Regorafenib (BAY 73-4506): Mechanism of Action

Regorafenib (BAY 73-4506) MOA：Targeting VEGFR2/Angiogenesis Pathway for Metastatic Colorectal Cancer

🎯 check Regorafenib (BAY 73-4506) product page

Regorafenib is a potent multi-kinase inhibitor. It affects MAPK signaling pathways, by blocking RTKs, to inhibit tumor growth.

Primary Applications and Mechanism of Action

Jump to: